<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-09-15</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39277784/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39277784-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: SGLT2 inhibition reduces serum uric acid in patients with CKD with larger effects at higher eGFR and in the absence of diabetes. However, the effect on uric acid is modest and did not translate into reduced risk of gout in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39277909/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Microbiome modulation of antigen presentation in tolerance and inflammation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39277909-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The microbiome regulates mammalian immune responses from early life to adulthood. Antigen presentation, orchestrating these responses, integrates commensal and pathogenic signals. However, the temporal and spatial specificity of microbiome impacts on antigen presentation and downstream tolerance versus inflammation remain incompletely understood. Herein, we review the influences of antigen presentation of microbiome-related epitopes on immunity; impacts of microbiome-based modulation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Ox4fMDPYq">Lands End夕阳西下的一刻。 美国·Lands End Lookout Cafe 子陵在听歌的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ox4fmdpyq/">
    
    
    
    
    
      
    
    Lands End夕阳西下的一刻。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->美国·Lands End Lookout Cafe<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png&quot;</a> referrerpolicy=&ldquo;no-referrer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oxbqt8PAB">昨天周六，工作到了凌晨1点。我们用sharepoint可以看到谁依然在访问数据页面，临床部门的主任和其他人也都在。其实对我而言，我没必要工作那么晚，但纯粹是OCD，...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oxbqt8pab/">
    
    
    
    
    
      
    
    昨天周六，工作到了凌晨1点。我们用sharepoint可以看到谁依然在访问数据页面，临床部门的主任和其他人也都在。其实对我而言，我没必要工作那么晚，但纯粹是OCD，怕有错误，所以一遍又一遍检查。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@子陵在听歌<!-- raw HTML omitted -->: 周五晚上11点了同事们还在核对数据。我今天跟我therapist说到这点，他说这对你来说不是工作，而是passion。其实在HIV领域，这么多年我认识的同事朋友很多人都是因为纯粹的passion而留在这个领域。尤其是现在，我看到每个数据点，都是一个活生生的人，对他们而言，经历HIV感染都是人生最大困境之一。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Ox5i2mJGh">期待最右的右右！//@有时右逝:终于！#缉妖录之启程篇定档# 提前祝我们“一手破天，一手改命”的吴道应初次登场能被诸位喜欢。[作揖] - 转发 @缉妖录之启程篇:&amp;en...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ox5i2mjgh/">
    
    
    
    
    
      
    
    期待最右的右右！//<!-- raw HTML omitted -->@有时右逝<!-- raw HTML omitted -->:终于！<!-- raw HTML omitted --><!-- raw HTML omitted -->#缉妖录之启程篇定档#<!-- raw HTML omitted --><!-- raw HTML omitted --> 提前祝我们“一手破天，一手改命”的吴道应初次登场能被诸位喜欢。<!-- raw HTML omitted -->&lt;img alt=&quot;[作揖]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/h_zuoyi-519f80d31c.pn">https://h5.sinaimg.cn/m/emoticon/icon/others/h_zuoyi-519f80d31c.pn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox97KeWNO">🔻菲 9701 舰侧面破洞处前后对比。#菲9701号船多次运补失败后撤离# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox97kewno/">
    
    
    
    
    
      
    
    🔻菲 9701 舰侧面破洞处前后对比。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#菲9701号船多次运补失败后撤离#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox9cCsPeD">🔻菲律宾 GMA 新闻发布了 9701 号舰长中校埃夫伦·杜兰不短舔着嘴唇“授勋”的视频。🔻可是，评论区菲律宾网民的回复则是：🔹“杜兰·杜兰在马尼拉的演唱...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox9ccsped/">
    
    
    
    
    
      
    
    🔻菲律宾 GMA 新闻发布了 9701 号舰长中校埃夫伦·杜兰不短舔着嘴唇“授勋”的视频。<!-- raw HTML omitted -->🔻可是，评论区菲律宾网民的回复则是：<!-- raw HTML omitted -->🔹“杜兰·杜兰在马尼拉的演唱会后（为小马科斯生日举办演唱会的英国乐队杜兰·杜兰），杜兰和他的船员离开了（Duran and his crew left after Duran Duran played in Manila）<!-- raw HTML omitted -->🔹“我军败了！菲律宾政府也遵循了中方的意愿（FAILED! Sumunod ang Philippine government sa gusto ng China）”<!-- raw HTML omitted -->🔹“哪一部分是‘任务完成’？唯有懦弱可见（saang parte ang “mission accomplished”？Kaduwagan lang ang nakikita）”<!-- raw HTML omitted -->🔹“他们很穷，而国会里的人却靠着本来可以购买 PCG 和 AFP 防御的钱，消费古驰包袋、劳力士手表、巴黎公寓、举办杜兰杜兰私人演唱会。可怜的菲律宾。报道这样的事情不觉得无聊吗（Kawawa sila habang ang mga nasa Congress nakahiga sa pera na pwede na sanang &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox9HP5joi">🔻目前初步计算路径和贝碧嘉一样。🔻是贝碧嘉之前轻装上阵留下来的部分？#台风普拉桑生成# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox9hp5joi/">
    
    
    
    
    
      
    
    🔻目前初步计算路径和贝碧嘉一样。<!-- raw HTML omitted -->🔻是贝碧嘉之前轻装上阵留下来的部分？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#台风普拉桑生成#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox9i8ef1l">🔻今天还有人说：“菲律宾自己的穷人都是捡吃剩的炸鸡吃的，你从这种角度说人家苦难?”🔻关于这个问题，教员同志于一九三九年九月二十八日写下的《苏联利益...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox9i8ef1l/">
    
    
    
    
    
      
    
    🔻今天还有人说：“菲律宾自己的穷人都是捡吃剩的炸鸡吃的，你从这种角度说人家苦难?”<!-- raw HTML omitted -->🔻关于这个问题，教员同志于一九三九年九月二十八日写下的《苏联利益和人类利益的一致》早已解答清楚了。<!-- raw HTML omitted -->🔹“在波兰政府方面，它是一个法西斯政府，是波兰地主资产阶级的反动政府，它残酷地剥削工农，压迫波兰的民主主义者；它又是一个大波兰主义的政府，因为它在波兰民族以外的许多少数民族中，即在乌克兰人、白俄罗斯人、犹太人、日耳曼人、立陶宛人等等一千余万人口的非波兰民族中，施行残酷的民族压迫，它本身是一个帝国主义的政府。”<!-- raw HTML omitted -->🔹“在这次战争中，波兰反动政府甘愿驱使波兰人民充当英法财政资本的炮灰，甘愿充当国际财政资本反动战线的一个组成部分。二十年来，波兰政府一贯地反对苏联，在英法苏谈判中，坚决地拒绝苏联军队的援助。而这个政府又是一个十分无能的政府，一百五十万以上的大军，不堪一击，仅仅在两个星期的时间中，就 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox9jP8g4H">菲9701号船以不专业、危险方式故意冲撞中方正常维权执法的5205舰，导致发生擦碰。 查看图片 //@他们又在背后说我帅:这个洞怎么造成的呢 - 转发 @包容万物恒河水:...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox9jp8g4h/">
    
    
    
    
    
      
    
    菲9701号船以不专业、危险方式故意冲撞中方正常维权执法的5205舰，导致发生擦碰。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->查看图片<!-- raw HTML omitted --><!-- raw HTML omitted --> //<!-- raw HTML omitted -->@他们又在背后说我帅<!-- raw HTML omitted -->:这个洞怎么造成的呢<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox9kY9Zvc">草，14号台风真的生成了，普拉桑。 评论配图 - 转发 @包容万物恒河水:&amp;ensp;🔻除了贝碧嘉以外，太平洋上还有96W、97W和98W。🔻其中97W有 中等 的机会在未来 ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox9ky9zvc/">
    
    
    
    
    
      
    
    草，14号台风真的生成了，普拉桑。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->评论配图<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻除了贝碧嘉以外，太平洋上还有96W、97W和98W。<!-- raw HTML omitted -->🔻其中97W有 中等 的机会在未来 24 小时内发展为热带气旋。那就是14号台风了。<!-- raw HTML omitted -->🔻路径可能和贝碧嘉差不多？&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox9lqFLvQ">🔻这可真是太妙了。🔻全世界人都得支持哈里斯了。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox9lqflvq/">
    
    
    
    
    
      
    
    🔻这可真是太妙了。<!-- raw HTML omitted -->🔻全世界人都得支持哈里斯了。 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox9SGuGAD">🔻贝碧嘉目前最大风速130公里/小时。🔻via JTWC#台风普拉桑生成# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox9sgugad/">
    
    
    
    
    
      
    
    🔻贝碧嘉目前最大风速130公里/小时。<!-- raw HTML omitted -->🔻via JTWC<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#台风普拉桑生成#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;div &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox9TA2WV5">🔻波兰尼萨的医院。🔻波兰这波，从波兰人发的各种视频里，从头到尾就没看见过波军。🔻你们资本主义的军队到底干啥用的？自己的老百姓不管，就去巴赫穆特替...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox9ta2wv5/">
    
    
    
    
    
      
    
    🔻波兰尼萨的医院。<!-- raw HTML omitted -->🔻波兰这波，从波兰人发的各种视频里，从头到尾就没看见过波军。<!-- raw HTML omitted -->🔻你们资本主义的军队到底干啥用的？自己的老百姓不管，就去巴赫穆特替乌克兰人打工用的吗？<!-- raw HTML omitted -->🔻via 火山迷灾害资讯网<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#热门视频#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png&quot;</a> referrerpolicy=&ldquo;no-ref &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OxaaM9TwG">🔻波兰人说：你能想象这样一条小河，水流突然大到直接垮吗？ [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oxaam9twg/">
    
    
    
    
    
      
    
    🔻波兰人说：你能想象这样一条小河，水流突然大到直接垮吗？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ox6Sl5mLX">久保史绪里 - 转发 @AyaTea:&amp;ensp;吉田绫乃#吉田绫乃クリスティー##吉田绫乃克莉丝蒂# 【Ins Story】 240914（1）今天的线下聊天会请多关照🍙（2）想拍照把手...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ox6sl5mlx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@AyaTea<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E5%90%89%E7%94%B0%E7%BB%AB%E4%B9%83&amp;amp;containeri">https://m.weibo.cn/p/index?extparam=%E5%90%89%E7%94%B0%E7%BB%AB%E4%B9%83&amp;amp;containeri</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ox7agr3uv">久保史绪里 via乃木坂46 X [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ox7agr3uv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->via乃木坂46 X <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39272698/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Prospective Comparison of Nine Different Handheld Ultrasound (HHUS) Devices by Ultrasound Experts with Regard to B-Scan Quality, Device Handling and Software in Abdominal Sonography</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39272698-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This is the first comprehensive study to directly compare different HHUS devices in a head-to-head manner. While the majority of the tested devices demonstrated satisfactory performance, notable discrepancies were observed between them. In particular, the B-scan quality exhibited considerable variation, which may have implications for the clinical application of HHUS. The findings of this study can assist in the selection of an appropriate HHUS device for specific &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39272752/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Impact of Structured Reporting of Lower Extremity CT Angiography on Report Quality and Workflow Efficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39272752-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We assessed the effects of structured reporting (SR) of lower extremity CT angiography (CTA) on report quality and workflow efficiency compared with conventional reports (CR). Surveys were conducted at an academic radiology department before and after the introduction of an SR template. Participants (n = 39, 21) rated report quality and report creation effort (1: very dissatisfied/low to 10: very satisfied/high) and whether SR represents an improvement over CR (1: completely disagree to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39272856/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39272856-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Combinations of immune-checkpoint inhibitors (ICIs) are the standard of care (SOC) for treatment-naive metastatic renal cell carcinoma (mRCC) patients. In this multicenter study, we evaluated the RW safety and efficacy of cabozantinib plus nivolumab in mRCC &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39272868/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39272868-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Percutaneous ablation is recommended in Barcelona Clinic Liver Cancer (BCLC) stage 0/A patients with HCC ≤3 cm as a curative treatment modality alongside surgical resection and liver transplantation. However, trans-arterial chemo-embolisation (TACE) is commonly used in the real-world as an initial treatment in patients with single small HCC in contrast to widely accepted clinical practice guidelines which typically describe TACE as a treatment for intermediate-stage HCC. We performed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273014/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">PDCD10 Is a Key Player in TMZ-Resistance and Tumor Cell Regrowth: Insights into Its Underlying Mechanism in Glioblastoma Cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273014-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Overcoming temozolomide (TMZ)-resistance is a major challenge in glioblastoma therapy. Therefore, identifying the key molecular player in chemo-resistance becomes urgent. We previously reported the downregulation of PDCD10 in primary glioblastoma patients and its tumor suppressor-like function in glioblastoma cells. Here, we demonstrate that the loss of PDCD10 causes a significant TMZ-resistance during treatment and promotes a rapid regrowth of tumor cells after treatment. PDCD10 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273106/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">BMP4-Induced Suppression of Breast Cancer Metastasis Is Associated with Inhibition of Cholesterol Biosynthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273106-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We reported previously that in preclinical models, BMP4 is a potent inhibitor of breast cancer metastasis and that high BMP4 protein levels predict favourable patient outcomes. Here, we analysed a breast cancer xenograft with or without enforced expression of BMP4 to gain insight into the mechanisms by which BMP4 suppresses metastasis. Transcriptomic analysis of cancer cells recovered from primary tumours and phosphoproteomic analyses of cancer cells exposed to recombinant BMP4 revealed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273234/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Effects of Oxiris&lt;sup&gt;®&lt;/sup&gt; Therapy on Cytokine Elimination after a LPS Infusion-An Experimental Animal Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273234-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The clinical effectiveness of Oxiris^(®), particularly in reducing cytokines, remains uncertain due to the limited data provided. This study explored and analyzed the application value of Oxiris^(®) endotoxin adsorption technology in a large animal model. Pigs received an intravenous LPS infusion. Six animals were treated 2 h after the infusion with an Oxiris^(®) hemadsorption using a pumpless extracorporeal technique for 6 h. Five animals served as controls. Cardiocirculatory &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273340/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Drug Repurposing Approach to Identify Candidate Drug Molecules for Hepatocellular Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273340-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, with a high mortality rate due to the limited therapeutic options. Systemic drug treatments improve the patient&rsquo;s life expectancy by only a few months. Furthermore, the development of novel small molecule chemotherapeutics is time-consuming and costly. Drug repurposing has been a successful strategy for identifying and utilizing new therapeutic options for diseases with limited treatment options. This study aims &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273340/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Drug Repurposing Approach to Identify Candidate Drug Molecules for Hepatocellular Carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273340-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, with a high mortality rate due to the limited therapeutic options. Systemic drug treatments improve the patient&rsquo;s life expectancy by only a few months. Furthermore, the development of novel small molecule chemotherapeutics is time-consuming and costly. Drug repurposing has been a successful strategy for identifying and utilizing new therapeutic options for diseases with limited treatment options. This study aims &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273499/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273499-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Immune activation status determines non-small cell lung cancer (NSCLC) prognosis, with reported positive/negative associations for T helper type 2 (TH2) responses, including allergen-specific IgE and eosinophils. Our study seeks to explore the potential impact of these comorbid immune responses on the survival rates of patients with NSCLC. Our retrospective study used data from the Data Warehouse of the German Center for Lung Research (DZL) and Lung Biobank at Thoraxklinik Heidelberg. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273499/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273499-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Immune activation status determines non-small cell lung cancer (NSCLC) prognosis, with reported positive/negative associations for T helper type 2 (TH2) responses, including allergen-specific IgE and eosinophils. Our study seeks to explore the potential impact of these comorbid immune responses on the survival rates of patients with NSCLC. Our retrospective study used data from the Data Warehouse of the German Center for Lung Research (DZL) and Lung Biobank at Thoraxklinik Heidelberg. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273576/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">The Molecular and Immunological Landscape of Meningiomas</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273576-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Meningiomas are the most common primary intracranial tumors in adults and typically have a slow-growing and benign nature. However, there is also a substantial subset of meningiomas that shows aggressive clinical behavior and is refractory to standard treatment modalities, which are still limited to surgery and/or radiotherapy. Despite intensive research, no systemic treatment options are yet available in the clinic for these challenging tumors, resulting in poor patient outcome. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273576/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">The Molecular and Immunological Landscape of Meningiomas</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273576-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Meningiomas are the most common primary intracranial tumors in adults and typically have a slow-growing and benign nature. However, there is also a substantial subset of meningiomas that shows aggressive clinical behavior and is refractory to standard treatment modalities, which are still limited to surgery and/or radiotherapy. Despite intensive research, no systemic treatment options are yet available in the clinic for these challenging tumors, resulting in poor patient outcome. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273646/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5&#43; Limbal Mesenchymal Stem Cell Population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273646-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Corneal transparency and avascularity are essential for vision. The avascular cornea transitions into the vascularized conjunctiva at the limbus. Here, we explore a limbal stromal cell sub-population that expresses ABCB5 and has mesenchymal stem cell characteristics. Human primary corneal stromal cells were enriched for ABCB5 by using FACS sorting. ABCB5+ cells expressed the MSC markers CD90, CD73, and CD105. ABCB5+ but not ABCB5- cells from the same donor displayed evidence of pluripotency &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39273646/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5&#43; Limbal Mesenchymal Stem Cell Population</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39273646-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Corneal transparency and avascularity are essential for vision. The avascular cornea transitions into the vascularized conjunctiva at the limbus. Here, we explore a limbal stromal cell sub-population that expresses ABCB5 and has mesenchymal stem cell characteristics. Human primary corneal stromal cells were enriched for ABCB5 by using FACS sorting. ABCB5+ cells expressed the MSC markers CD90, CD73, and CD105. ABCB5+ but not ABCB5- cells from the same donor displayed evidence of pluripotency &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274320/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274320-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274320/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274320-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274363/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274363-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Objective: This study investigates age-related differences and outcomes in patients hospitalized with heart failure with a mildly reduced ejection fraction (HFmrEF). Background: The characterization of patients with HFmrEF and the prognostic value of age has rarely been investigated. Methods: Patients with HFmrEF were retrospectively included at one institution between 2016 and 2022. The distribution of HF aetiology and prognostic outcomes were investigated comparing patients with ≤40, &gt;40 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274363/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274363-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Objective: This study investigates age-related differences and outcomes in patients hospitalized with heart failure with a mildly reduced ejection fraction (HFmrEF). Background: The characterization of patients with HFmrEF and the prognostic value of age has rarely been investigated. Methods: Patients with HFmrEF were retrospectively included at one institution between 2016 and 2022. The distribution of HF aetiology and prognostic outcomes were investigated comparing patients with ≤40, &gt;40 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274400/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Mid-Term Migration Pattern of a Cemented Collared Anatomical Stem-A Retrospective Study Using EBRA-FCA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274400-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Aseptic loosening is one of the leading causes of stem revision. Einzel Bild Röntgen Analyse-Femoral Component Analysis allows for the detection of distal stem migration, which is used as a predictive factor for implant longevity. This study aims to demonstrate the migration behavior of a cemented collared anatomical stem. Methods: This study retrospectively examined all patients who received a cemented Lubinus SP II stem (Waldemar Link, Hamburg, Germany) between 2003 and 2019. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274400/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Mid-Term Migration Pattern of a Cemented Collared Anatomical Stem-A Retrospective Study Using EBRA-FCA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274400-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Aseptic loosening is one of the leading causes of stem revision. Einzel Bild Röntgen Analyse-Femoral Component Analysis allows for the detection of distal stem migration, which is used as a predictive factor for implant longevity. This study aims to demonstrate the migration behavior of a cemented collared anatomical stem. Methods: This study retrospectively examined all patients who received a cemented Lubinus SP II stem (Waldemar Link, Hamburg, Germany) between 2003 and 2019. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274457/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Feasibility and Safety of 3D-Navigated Trans-Sacral Bar Osteosynthesis for Fragility Fractures of the Sacrum: FIRST Clinical Experiences</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274457-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: There has been an increasing number of fragility fractures of the sacrum in the recent decade. With rates of up to 28%, the complication rates after surgical treatment are still at an unacceptably high level, and new treatment strategies are urgently needed. Therefore, the purpose of this study was to evaluate the potential of 3D-navigated trans-sacral bar osteosynthesis in the surgical treatment of fragility fractures of the sacrum. Methods: Retrospectively, from 2017 to 2023, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274457/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Feasibility and Safety of 3D-Navigated Trans-Sacral Bar Osteosynthesis for Fragility Fractures of the Sacrum: FIRST Clinical Experiences</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274457-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: There has been an increasing number of fragility fractures of the sacrum in the recent decade. With rates of up to 28%, the complication rates after surgical treatment are still at an unacceptably high level, and new treatment strategies are urgently needed. Therefore, the purpose of this study was to evaluate the potential of 3D-navigated trans-sacral bar osteosynthesis in the surgical treatment of fragility fractures of the sacrum. Methods: Retrospectively, from 2017 to 2023, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274611/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Dimensional Accuracy of Novel Vinyl Polysiloxane Compared with Polyether Impression Materials: An In Vitro Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274611-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Transferring the intraoral situation accurately to the dental laboratory is crucial for fabricating precise restorations. This study aimed to compare the dimensional accuracy of a new hydrophilic quadrofunctional vinyl polysiloxane (VPS) and polyether (PE), in combination with different impression techniques (mono-phase single step or dual-phase single step). The reference model simulated a partially edentulous mandible. Stainless-steel precision balls were welded to specific teeth and were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39274611/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Dimensional Accuracy of Novel Vinyl Polysiloxane Compared with Polyether Impression Materials: An In Vitro Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39274611-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Transferring the intraoral situation accurately to the dental laboratory is crucial for fabricating precise restorations. This study aimed to compare the dimensional accuracy of a new hydrophilic quadrofunctional vinyl polysiloxane (VPS) and polyether (PE), in combination with different impression techniques (mono-phase single step or dual-phase single step). The reference model simulated a partially edentulous mandible. Stainless-steel precision balls were welded to specific teeth and were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39275979/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Setting up an institutional OMERO environment for bioimage data: Perspectives from both facility staff and users</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39275979-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Modern bioimaging core facilities at research institutions are essential for managing and maintaining high-end instruments, providing training and support for researchers in experimental design, image acquisition and data analysis. An important task for these facilities is the professional management of complex multidimensional bioimaging data, which are often produced in large quantity and very different file formats. This article details the process that led to successfully implementing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39275979/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Setting up an institutional OMERO environment for bioimage data: Perspectives from both facility staff and users</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39275979-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Modern bioimaging core facilities at research institutions are essential for managing and maintaining high-end instruments, providing training and support for researchers in experimental design, image acquisition and data analysis. An important task for these facilities is the professional management of complex multidimensional bioimaging data, which are often produced in large quantity and very different file formats. This article details the process that led to successfully implementing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276119/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Factors Influencing Long-term Outcomes After Matrix-Induced Autologous Chondrocyte Implantation: Long-term Results at 10 Years</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276119-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The present study shows consistently good long-term clinical outcomes after MACI with a low revision rate and high patient satisfaction. BMI and number of previous knee surgeries may influence clinical outcomes and should be considered in patient selection and education. There is a correlation between graft structure, subchondral bone changes on magnetic resonance imaging, and long-term &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276119/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Factors Influencing Long-term Outcomes After Matrix-Induced Autologous Chondrocyte Implantation: Long-term Results at 10 Years</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276119-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The present study shows consistently good long-term clinical outcomes after MACI with a low revision rate and high patient satisfaction. BMI and number of previous knee surgeries may influence clinical outcomes and should be considered in patient selection and education. There is a correlation between graft structure, subchondral bone changes on magnetic resonance imaging, and long-term &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">EuMAR stakeholder engagement: an analysis of medically assisted reproduction (MAR) data collection practices in EU countries†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    STUDY QUESTION: What are the current national medically assisted reproduction (MAR) data collection systems across EU Member States, and how can these countries contribute to a unique, cycle-by-cycle registry for the European Monitoring of Medically Assisted Reproduction (EuMAR) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">EuMAR stakeholder engagement: an analysis of medically assisted reproduction (MAR) data collection practices in EU countries†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    STUDY QUESTION: What are the current national medically assisted reproduction (MAR) data collection systems across EU Member States, and how can these countries contribute to a unique, cycle-by-cycle registry for the European Monitoring of Medically Assisted Reproduction (EuMAR) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276227/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240914193229&amp;v=2.18.0.post9&#43;e462414">Digital remote monitoring of chronic retinal conditions-A clinical future tool? : Remote monitoring of chronic retinal conditions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276227-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240914193229-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Remote monitoring could complement existing care structures for patients with chronic retinal diseases, especially AMD and DED. Promising systems are based on hyperacuity or optical coherence tomography, while patient-reported data are not commonly used; however, there is currently insufficient evidence justifying the use of remote monitoring systems in chronic retinal diseases in Europe and more research on the validation of remote monitoring systems is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276227/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Digital remote monitoring of chronic retinal conditions-A clinical future tool? : Remote monitoring of chronic retinal conditions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276227-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Remote monitoring could complement existing care structures for patients with chronic retinal diseases, especially AMD and DED. Promising systems are based on hyperacuity or optical coherence tomography, while patient-reported data are not commonly used; however, there is currently insufficient evidence justifying the use of remote monitoring systems in chronic retinal diseases in Europe and more research on the validation of remote monitoring systems is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276347/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Integrated metabolic-transcriptomic network identifies immunometabolic modulations in human macrophages</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276347-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Macrophages exhibit diverse phenotypes and respond flexibly to environmental cues through metabolic remodeling. In this study, we present a comprehensive multi-omics dataset integrating intra- and extracellular metabolomes with transcriptomic data to investigate the metabolic impact on human macrophage function. Our analysis establishes a metabolite-gene correlation network that characterizes macrophage activation. We find that the concurrent inhibition of tryptophan catabolism by IDO1 and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276525/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Response to letter to the editor regarding &#34;low intraoperative end-tidal carbon dioxide levels are associated with improved recurrence-free survival after elective colorectal cancer surgery&#34;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276525-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276594/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276594-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Although deep learning models trained on larger cohorts show improved robustness and generalizability in predicting oncogenic mutations, they cannot replace comprehensive molecular profiling. However, they may support patient pre-selection for clinical trials and deepen the insight in genotype-phenotype &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276631/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">A Picture Corrects a Thousand Words - The Effect of Photos on Veracity Feedback</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276631-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The truthiness effect (Newman et al., 2012) refers to the belief that any particular stimulus is truthful when it is accompanied by nonprobative information (e.g., a photograph). Accordingly, photo-accompanied statements are more likely to be judged as truthful compared to statements without a photo. In an online experiment (N = 98) with two assessment times, we aimed to replicate this effect and its persistence over time. Furthermore, we were interested in to what extent feedback on the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39276977/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240915192147&amp;v=2.18.0.post9&#43;e462414">Implications of GLI spirometry reference equations in Northeast Asian patients with COPD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39276977-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240915192147-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Accurate spirometry interpretation is critical in the diagnosis and management of chronic obstructive pulmonary disease (COPD). With increasing efforts for a unified approach by the Global Lung Function Initiative (GLI), this study evaluated the application of race-specific 2012-GLI and race-neutral 2022-GLI reference equations compared to Choi&rsquo;s reference equations, which is derived and widely used in South Korea, for spirometry interpretation in Northeast Asian patients with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OwUyY8KpD">今天therapist说”off record, I enjoy talking to you”。我们用了很久聊了CBT循证，然后我给他看了一下我们昨天新闻发布，解释了临床试验意义。我说我们工作都...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-owuyy8kpd/">
    
    
    
    
    
      
    
    今天therapist说”off record, I enjoy talking to you”。我们用了很久聊了CBT循证，然后我给他看了一下我们昨天新闻发布，解释了临床试验意义。我说我们工作都是看chart。我觉得最近几次我们更像是同事讨论项目和数据，而不是在做therapy。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OwWkdjfbv">周五晚上11点了同事们还在核对数据。我今天跟我therapist说到这点，他说这对你来说不是工作，而是passion。其实在HIV领域，这么多年我认识的同事朋友很多人都是...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-owwkdjfbv/">
    
    
    
    
    
      
    
    周五晚上11点了同事们还在核对数据。我今天跟我therapist说到这点，他说这对你来说不是工作，而是passion。其实在HIV领域，这么多年我认识的同事朋友很多人都是因为纯粹的passion而留在这个领域。尤其是现在，我看到每个数据点，都是一个活生生的人，对他们而言，经历HIV感染都是人生最大困境之一。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OwXmc0v5b">Barouch组在Nature Med发表了一项HIV中和抗体（bNAbs）用于HIV治疗的临床试验结果，这是该研究组从恒河猴模型转型临床试验后第二篇中和抗体临床试验研究论文，之...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-owxmc0v5b/">
    
    
    
    
    
      
    
    Barouch组在Nature Med发表了一项HIV中和抗体（bNAbs）用于HIV治疗的临床试验结果，这是该研究组从恒河猴模型转型临床试验后第二篇中和抗体临床试验研究论文，之前的研究结果同样发表在了Nature Med上（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->）；这也是之前研究的后续研究，为HIV-1  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OwUKJ34Yd">敦煌博物馆门口，有一家动物医院。一看就是专为牛、马、马喽这样的动物看病的，白领动物如狗、鹦鹉、蜥蜴之类，大概有更高级的对口医院。至于金领猫，恐怕是专属...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-owukj34yd/">
    
    
    
    
    
      
    
    敦煌博物馆门口，有一家动物医院。一看就是专为牛、马、马喽这样的动物看病的，白领动物如狗、鹦鹉、蜥蜴之类，大概有更高级的对口医院。至于金领猫，恐怕是专属家庭医生了吧？ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OwVSUqKBx">路遇一家孟婆粉……店主好像忘了开店了 查看图片 - 转发 @马伯庸:&amp;ensp;敦煌博物馆门口，有一家动物医院。一看就是专为牛、马、马喽这样的动物看病的，白领动物...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-owvsuqkbx/">
    
    
    
    
    
      
    
    路遇一家孟婆粉……店主好像忘了开店了 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->查看图片<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@马伯庸<!-- raw HTML omitted -->: 敦煌博物馆门口，有一家动物医院。一看就是专为牛、马、马喽这样的动物看病的，白领动物如狗、鹦鹉、蜥蜴之类，大概有更高级的对口医院。至于金领猫 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0dDthdx">🔻看了第四局，年轻人打的挺好的。#王楚钦vs林诗栋#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0ddthdx/">
    
    
    
    
    
      
    
    🔻看了第四局，年轻人打的挺好的。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#王楚钦vs林诗栋#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0eD7ad6">但是有些有责任核实信息的有影响力帐号也跟着在这儿欢呼“外国人整顿相亲市场”了，就没意思了，骗骗自己就行了呗，还真骗哥们儿啊？//@包容万物恒河水:其实也没...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0ed7ad6/">
    
    
    
    
    
      
    
    但是有些有责任核实信息的有影响力帐号也跟着在这儿欢呼“外国人整顿相亲市场”了，就没意思了，骗骗自己就行了呗，还真骗哥们儿啊？//<!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->:其实也没啥，一种创作思路嘛。除了增加有些哥们儿的焦虑以外也没有什么别的坏处。毕竟不是一个赛道的。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻视频1帐号 C妹在成都，抖音118.3万粉。<!-- raw HTML omitted -->🔻视频2帐号 JC在成都，抖音111.9万粉。<!-- raw HTML omitted -->🔻视频3帐号 阿珍在北京，抖音133.7万粉。<!-- raw HTML omitted -->🔻视频4帐号 LUNA在广州，抖音159.9万粉。<!-- raw HTML omitted -->🔻这些帐号商务合作帐号联系人一样，有业务需求的，联系一个就行了，省事省心。 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b">https://tvax3.sinaimg.cn/large/639b</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0g2hiTF">🔻印度的公路塌方都很有辨析度。🔻via 火山迷灾害资讯网#热门视频# 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0g2hitf/">
    
    
    
    
    
      
    
    🔻印度的公路塌方都很有辨析度。<!-- raw HTML omitted -->🔻via 火山迷灾害资讯网<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#热门视频#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div style=&ldquo;clear: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0Q8rghy">你怎么知道我买了原价的哈立德1礼包？//@许诺不想说话:包姐别急，早晚会有属于你的拉夫驾着巨大天燕90来迎娶你[doge] - 转发 @包容万物恒河水:&amp;ensp;🔻互联网...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0q8rghy/">
    
    
    
    
    
      
    
    你怎么知道我买了原价的哈立德1礼包？//<!-- raw HTML omitted -->@许诺不想说话<!-- raw HTML omitted -->:包姐别急，早晚会有属于你的拉夫驾着巨大天燕90来迎娶你<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻互联网上每个群体，都能匹配到适合自己的伏拉夫。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0rMf5SR">伊戈尔·维克托罗维奇·普济克在顿涅茨克名气挺大，现在是上校，话说 DNR 内部丑闻也不少，仔细想想那么多战斗英雄陆陆续续是怎么被暗杀的。很多人因为这件事曝...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0rmf5sr/">
    
    
    
    
    
      
    
    伊戈尔·维克托罗维奇·普济克在顿涅茨克名气挺大，现在是上校，话说 DNR 内部丑闻也不少，仔细想想那么多战斗英雄陆陆续续是怎么被暗杀的。很多人因为这件事曝光，又把拉塞尔·本特利案联系在了一起。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@呦吼啊呦吼呦吼<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#俄乌局势#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%BF%84%E4%B9%8C%E5%B1%80%E5%8A%BF%E6%96%B0%E8%BF%9B%E5%B1%95%23&amp;amp;extparam=%23%E4%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%BF%84%E4%B9%8C%E5%B1%80%E5%8A%BF%E6%96%B0%E8%BF%9B%E5%B1%95%23&amp;amp;extparam=%23%E4%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0vNjVFP">🔻互联网上每个群体，都能匹配到适合自己的伏拉夫。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0vnjvfp/">
    
    
    
    
    
      
    
    🔻互联网上每个群体，都能匹配到适合自己的伏拉夫。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox0yXwfiP">🔻谢谢守夜人，晚安。 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox0yxwfip/">
    
    
    
    
    
      
    
    🔻谢谢守夜人，晚安。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox14PCnBL">🔻俄罗斯国防部官网：🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局长维克托-戈列米金上将、俄罗斯联邦武装力量总...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox14pcnbl/">
    
    
    
    
    
      
    
    🔻俄罗斯国防部官网：<!-- raw HTML omitted -->🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局长维克托-戈列米金上将、俄罗斯联邦武装力量总参谋长兼俄罗斯联邦国防部第一副部长瓦列里-格拉西莫夫陆军上将，立即与俄罗斯联邦安全局军事反情报司一道，尽快处理与两名呼号为‘欧内斯特’和‘康斯坦丁’的军人死 亡 有 关 的 案件。”<!-- raw HTML omitted -->🔻众所周知，别洛索夫领受着普京的任务，正在俄罗斯国防部内大刀阔斧清理门户。<!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1htnsjne50rj20p017n7pd.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbly1htnsjne50rj20p017n7pd.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox1ehtrGz">打雷呢，没办法，打战雷吧。//@bbq77882011:包姐，2点多了，还没睡啊？ - 转发 @包容万物恒河水:&amp;ensp;🔻俄罗斯国防部官网：🔻“俄联邦国防部长别洛索夫已命...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox1ehtrgz/">
    
    
    
    
    
      
    
    打雷呢，没办法，打战雷吧。//<!-- raw HTML omitted -->@bbq77882011<!-- raw HTML omitted -->:包姐，2点多了，还没睡啊？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻俄罗斯国防部官网：<!-- raw HTML omitted -->🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局长维克托-戈列米金上将、俄罗斯联邦武装力量总参谋长兼俄罗斯联邦国防部第一副部长瓦列里-格拉西莫夫陆军上将，立即与俄罗斯联邦安全局军事反情报司一道，尽快处理与两名呼号为‘欧内斯特’和‘康斯坦丁’的军人死 亡 有 关 的 案件。”<!-- raw HTML omitted -->🔻众所周知，别洛索夫领受着普京的任务，正在俄罗斯国防部内大刀阔斧清理门户。&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bf">https://tvax3.sinaimg.cn/large/639b1bf</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ox1xZBA9U">新官上任三把火 - 转发 @包容万物恒河水:&amp;ensp;🔻俄罗斯国防部官网：🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ox1xzba9u/">
    
    
    
    
    
      
    
    新官上任三把火<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻俄罗斯国防部官网：<!-- raw HTML omitted -->🔻“俄联邦国防部长别洛索夫已命令：俄联邦国防部副部长兼俄联邦武装力量军事政治总局局长维克托-戈列米金上将、俄罗斯联邦武装力量总参谋长兼俄罗斯联邦国防部第一副部长瓦列里-格拉西莫夫陆军上将，立即与俄罗斯联邦安全局军事反情报司一道，尽快处理与两名呼号为‘欧内斯特’和‘康斯坦丁’的军人死 亡 有 关 的 案件。”<!-- raw HTML omitted -->🔻众所周知，别洛索夫领受着普京的任务，正在俄罗斯国防部内大刀阔斧清理门户。<!-- raw HTML omitted -->&lt;img style=&quot;&quot;  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OwWkQ6m1n">久保用大姐手機拍的自拍照 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-owwkq6m1n/">
    
    
    
    
    
      
    
    久保用大姐手機拍的自拍照 <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OwYwZETGY">怎麼這麼好看啊！ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-owywzetgy/">
    
    
    
    
    
      
    
    怎麼這麼好看啊！ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwXsPnauM">久保史绪里#久保史绪里手机博# 2024.09.14 13:57「时钟」早上好今天也努力吧今早时隔许久地起来得很干脆呢虽然也会有害怕起床的日子和很难起床的日子但是要努力...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owxspnaum/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%258">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwXtEdO8q">久保史绪里#shiorigram# 被找到了🫣 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owxtedo8q/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->被找到了🫣 &lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwYls0ist">久保史绪里[抱一抱] - 转发 @長亭梅:&amp;ensp;梅泽美波#梅泽美波# 夏のツアー、完走しました乃木坂で過ごす夏はいつも、単純には終われません。感情が 凄まじく動く...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owyls0ist/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[抱一抱]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/co_a1hug-f3910d0e88.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/co_a1hug-f3910d0e88.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwYqycZrD">久保史绪里[亲亲] - 转发 @特蕾纱熊猫観察会:&amp;ensp;池田瑛纱#terepantalk# 5566｜2024-09-14 20:04:26｜图片 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owyqyczrd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OwYrvzm52">久保史绪里[哇] - 转发 @特蕾纱熊猫観察会:&amp;ensp;池田瑛纱#terepantalk# 5567｜2024-09-14 20:04:45｜图片 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-09-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-owyrvzm52/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;blockquo &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

